UNSPSC 51181610: Montirelin

This classification denotes a thyrotropin-releasing hormone analogue with the molecular formula C17H24N6O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30MUJ6YYUY, chemically known as (-)-n-(((3r,6s)-6-methyl-5-oxo-3-thiomorpholinyl)carbonyl)-l-histidyl-l-prolinamide but generally known as montirelin, which bears US NIH Compound Identifier 65815. European Medicines Agency schedules Montirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09056MIG.

I cannot write a summary for this UNSPSC code. The source provides only a UNSPSC number (51181610) and a product name (Montirelin) with no description of the code's scope, no block of recent state and local opportunities, and no information about issuing bodies, geographies, or representative solicitations.

To produce a decision-relevant summary, I need the <most-recent-state-local-contract-opportunities> block populated with actual posted opportunities, or at minimum a functional description of what the code covers. Without that, I cannot ground the summary in what state and local governments are actually buying under this code.

Please provide the recent-opportunities block or additional source material that includes posted solicitations, issuing bodies, notice types, and response dates.